|
Markt geschlossen -
Bombay S.E.
12:02:25 15.10.2026
|
Perf. 5 T | Veränd. 1. Jan. | ||
| 2’523.00 INR | -0.65% |
|
-0.46% | +2.11% |
| 03.08. | GSK India: Gewinn im ersten Quartal steigt dank stabiler Impfstoffnachfrage | RE |
| 03.08. | GlaxoSmithKline Pharmaceuticals Limited legt Ergebnisse für das erste Quartal zum 30. Juni 2026 vor | CI |
Hauptkonkurrenten
| % | % 5 Tage | Veränd. 1 Monat | Veränd. 3 Monate | % 1. Jan. | Perf. 1 Jahr | Perf. 3 Jahre | Veränd. 5 Jahre | Veränd. 10 Jahre | Marktkap.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| -0.65% | -0.46% | -10.34% | +1.50% | +2.11% | -7.80% | +63.88% | +71.09% | +70.53% | 4.52 Mrd. | ||
| +3.90% | +7.26% | +10.42% | +8.46% | +16.73% | +51.77% | +103.44% | +427.36% | +1’497.45% | 1’077 Mrd. | ||
| +2.48% | +1.63% | -2.45% | +5.52% | +25.95% | +36.35% | +65.47% | +61.60% | +119.98% | 612 Mrd. | ||
| +2.63% | +6.48% | +10.28% | +18.83% | +26.96% | +28.23% | +97.03% | +165.33% | +382.34% | 501 Mrd. | ||
| +2.15% | +6.21% | +5.16% | +22.33% | +43.66% | +79.78% | +45.20% | +93.05% | +145.80% | 364 Mrd. | ||
| +1.90% | +6.83% | +4.49% | +14.11% | +14.81% | +32.63% | +49.43% | +4.59% | +61.93% | 353 Mrd. | ||
| +2.14% | +6.44% | +10.07% | +2.70% | +14.32% | +20.43% | +43.69% | +62.88% | +68.19% | 278 Mrd. | ||
| +3.36% | +7.13% | +5.15% | +1.38% | -7.61% | +0.76% | +16.11% | +44.86% | +156.11% | 251 Mrd. | ||
| +3.19% | +7.64% | +16.75% | +22.40% | +33.99% | +47.51% | +52.88% | +111.01% | +169.69% | 230 Mrd. | ||
| +3.23% | +8.26% | +8.85% | +20.92% | +29.75% | +34.62% | +101.07% | +135.47% | +119.23% | 190 Mrd. | ||
| +2.60% | +4.80% | -5.07% | -20.77% | -19.48% | -28.03% | -62.95% | -20.40% | +92.15% | 168 Mrd. | ||
| +1.93% | +7.14% | +8.19% | +20.08% | +19.70% | +22.20% | -10.41% | -28.16% | -8.29% | 166 Mrd. | ||
| +3.69% | +2.06% | -0.19% | +7.66% | +13.29% | +25.92% | +37.33% | +182.57% | +538.05% | 126 Mrd. | ||
| +4.41% | +3.72% | -3.04% | +5.24% | +14.56% | +41.70% | +8.09% | +5.89% | +25.24% | 121 Mrd. | ||
| +2.21% | +7.15% | +10.81% | +25.17% | +21.52% | +25.87% | +118.94% | +388.22% | +520.48% | 114 Mrd. | ||
| +1.00% | +2.30% | -2.22% | -4.85% | -12.28% | -13.91% | -30.15% | -13.45% | +6.89% | 95.7 Mrd. | ||
| +3.01% | +7.72% | +0.84% | -2.45% | +2.47% | +14.83% | +25.20% | +6.86% | -10.17% | 95.69 Mrd. | ||
| +2.57% | +16.41% | +59.50% | +235.85% | +677.62% | +727.27% | +149.42% | -29.27% | - | 90.35 Mrd. | ||
| +2.87% | +8.01% | +3.19% | +20.22% | +3.49% | +38.58% | -5.31% | +44.39% | +117.82% | 77.72 Mrd. | ||
| +0.97% | +5.27% | +9.13% | +1.96% | +16.52% | +22.67% | -4.35% | -25.73% | +47.09% | 68.62 Mrd. | ||
| Durchschnitt | +2.53% | +2.36% | +6.98% | +20.31% | +46.90% | +60.07% | +43.20% | +84.41% | +216.87% | 249.27 Mrd. | |
| Nach Marktkapitalisierung gewichteter Durchschnitt | +2.94% | +1.90% | +7.10% | +14.42% | +30.42% | +47.47% | +60.40% | +151.46% | +455.56% |
- Börse
- Aktien
- 946008 Aktie
- Sektor GlaxoSmithKline Pharmaceuticals Limited
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen
















